You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK – INanoBio said today that it will receive up to $5.4 million over four years from the Defense Advanced Research Projects Agency (DARPA) to develop a nanopore technology for epigenetic sequencing.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.
CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.
In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.
This webinar will discuss a streamlined library preparation method for next-generation sequencing (NGS) that improves quality control testing capability while reducing the total number of steps compared to conventional multiplexed library workflows.
NTRK fusions are oncogenic drivers in a variety of tumors.
Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure.